BioArctic AB (publ) (STO:BIOA.B)
300.60
-5.60 (-1.83%)
Nov 20, 2026, 5:29 PM CET
BioArctic AB Market Cap
BioArctic AB has a market cap or net worth of 26.67 billion as of November 20, 2026. It is the 5,300th most valuable company in the world and the 64th biggest in Sweden. Its market cap has increased by 6.47% in one year.
Market Cap
26.67B
Enterprise Value
24.77B
Revenue
1.00B
Global Rank
Country Rank
#64 Sweden
PE Ratio
253.81
ChartMarket Cap Chart
Since October 12, 2017, BioArctic AB's market cap has increased from 2.55B to 26.67B, an increase of 944.37%. That is a compound annual growth rate of 29.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 26.67B | -3.19% |
| Dec 30, 2025 | 27.55B | 56.23% |
| Dec 30, 2024 | 17.63B | -25.44% |
| Dec 29, 2023 | 23.65B | -1.34% |
| Dec 30, 2022 | 23.97B | 128.37% |
| Dec 30, 2021 | 10.50B | 24.95% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Camurus AB | 44.01B |
| Egetis Therapeutics AB | 5.17B |
| Hansa Biopharma AB | 4.59B |
| Vicore Pharma Holding AB | 2.77B |
| Saniona AB | 1.55B |
| Genovis AB (publ.) | 1.53B |
| Flerie AB | 1.08B |
| Infant Bacterial Therapeutics AB | 934.92M |